GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH

Overview of attention for article published in Frontiers in endocrinology, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets

twitter: 3 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 48 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

The Possible Roles of GLP-1: Emerging Insights

Georgia Today, 08 Aug 2024

The glucagon-like peptide-1 (GLP-1) is an incretin hormone pivotal in metabolic regulation within various organisms.

不止减肥和降糖！GLP-1多肽的下一个适应症：阿尔茨海默病

CN-Healthcare, 08 Sep 2023

GLP-1多肽的加入，是否会将阿尔茨海默病进一步逼向墙角，学术界与产业界都在拭目以待。来源：药渡/撰文：哥哈骎生物制药领域目前可能没有比GLP-1多肽更给人一日千里的感受了。除了在糖尿病、肥胖症、非酒精性脂肪肝病（NAFLD）、非酒精性脂肪性肝炎（NAS…

GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH.

Alzforum, 01 Oct 2021

Li QX, Gao H, Guo YX, Wang BY, Hua RX, Gao L, Shang HW, Lu X, Xu JD. Front Endocrinol (Lausanne).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.